Open AccessMedical and Revascularization Management of Stable Ischemic Heart Disease: An Overview
Author(s) -
Qais Radaideh,
Nicolas W. Shammas,
Ghassan Daher,
Rayan Jo Rachwan
Publication year - 2021
Publication title -
international journal of angiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.293
H-Index - 26
eISSN - 1615-5939
pISSN - 1061-1711
DOI - 10.1055/s-0040-1722739
Subject(s) - medicine , medical therapy , revascularization , stable angina , cardiology , disease , percutaneous coronary intervention , angina , ischemia , angiology , coronary artery disease , intensive care medicine , myocardial infarction
Stable ischemic heart disease (SIHD) affects approximately 10 million Americans with 500,000 new cases diagnosed each year. Patients with SIHD are primarily managed in the outpatient setting with aggressive cardiovascular risk factor modification via medical therapy and lifestyle changes. Currently, this approach is considered as the mainstay of treatment. The recently published ISCHEMIA trial has established the noninferiority of medical therapy in comparison to coronary revascularization in patients with moderate to severe ischemia. Percutaneous coronary intervention is currently recommended for patients with significant left main disease, large ischemic myocardial burden, and patients with severe refractory angina despite maximal medical therapy.